市場調査レポート

商品コード

1577236

補助人工心臓（VAD）市場の2030年までの予測：製品別、設計別、フロータイプ別、用途別、エンドユーザー別、地域別の世界分析

Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product, Design, Type of Flow, Application, End User and By Geography

出版日: 2024年10月10日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 610,008円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 771,697円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 933,386円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,102,425円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、補助人工心臓（VAD）の世界市場は2024年に36億米ドルを占め、予測期間中のCAGRは19.6％で成長し、2030年には107億米ドルに達する見込みです。

補助人工心臓（VAD）と呼ばれる機械式ポンプは、心室が血液を体内に送り出すのを助け、心臓機能をサポートします。移植手術の候補でない患者、心不全が著しい患者、心臓移植を待っている患者が頻繁に利用しています。補助人工心臓は片側または両方の心室に挿入することができ、最も頻繁に使用されるのは左心室（LVAD）、右心室（RVAD）、またはその両方（BiVAD）です。これらは患者の生活水準を高め、血流を増加させ、心臓の負担を軽減します。

米国心臓協会（AHA）によると、米国では2030年までに心不全の有病率が大幅に増加し、患者数は800万人を超えると予測されています。2020年には、世界全体で550万人以上が心不全に罹患しています。高齢者は心不全のリスクが高いです。そのため、老年人口の増加もこの疾患の蔓延に拍車をかけています。

心不全の世界的有病率

裕福な国々では、心不全は人口の1～2％が罹患しています。予測によると、2030年までに約800万人のアメリカ人が罹患する可能性があります。心不全患者の増加は、補助人工心臓の必要性を高める大きな要因です。さらに、糖尿病や高血圧といった高齢化社会によく見られる慢性疾患が心不全患者増加の主な原因であり、利用可能な心臓ドナーの不足によって補助人工心臓の需要が高まっています。

移植に伴うリスク

出血リスクの増大は補助人工心臓の植え込みに伴う外科的結果の一つであり、抗凝固薬の投与は事態を悪化させる可能性があります。コントローラーや電源装置のような外部部品は感染症の侵入口となる可能性があり、深刻な問題を引き起こし、移植後の死亡率を上昇させる。血栓症は、脳卒中やポンプ故障を引き起こす可能性があるため、抗凝固療法レベルの慎重なモニタリングが必要な、機器に関連した結果の1つです。さらに、心臓への負担の増大によって引き起こされる右室機能障害は、患者の転帰を複雑にし、さらなる処置が必要になる可能性があります。

補助人工心臓技術の絶え間ない革新

技術の進歩により、より堅牢でコンパクトな装置が開発され、患者の快適性と移動性が向上しました。生体適合性の進歩は血栓症や感染症のリスクを低下させ、患者導入の障害を軽減しています。補助人工心臓治療は、小型化による低侵襲性のおかげで、より多くの患者がより広く利用できるようになり、回復時間も短縮され、移植プロセスもより単純になった。

不十分な償還政策と保険適用

補助人工心臓は植え込み手術だけでなく術後のケアも必要であり、費用がかさむことがあります。保険適用が不十分なために多額の自己負担金を支払わなければならない場合、患者は補助人工心臓治療を選択することをためらうかもしれないです。医療への十分なアクセスは、医療介入の延期や放棄、健康状態の悪化、長期的なヘルスケア費用の増加につながり、最終的に補助人工心臓の市場需要を減少させる。

COVID-19の影響：

COVID-19パンデミックは、選択的手術の大幅な遅れとデバイス利用率の低下を引き起こし、補助人工心臓（VAD）市場に悪影響を与えました。ロックダウンや渡航制限により、多くの患者が安全性への懸念から治療を延期したため、補助人工心臓の移植件数は減少しました。その結果、補助人工心臓の需要が減少し、メーカーやヘルスケアプロバイダーの収益に影響を与えました。しかし、規制が緩和されるにつれて、患者の受診や処置の回復が予想され、その後の市場成長を活性化させる可能性があります。

予測期間中、両補助人工心臓（VAD）セグメントが最大になる見込み

両補助人工心臓（VAD）分野は、全人工心臓（TAH）移植シナリオにおける装置性能と有用性を向上させる空気圧駆動システムなどのBiVAD技術における需要の増加と進歩により、予測期間中に最大となる見込みです。より良い血行動態のサポート、生活の質の改善、生存率の向上、患者と医師の受容性の向上はすべてBiVADによって達成されます。

予測期間中にCAGRが最も高くなると予想されるのは、ブリッジから移植へのセグメントです。

心臓移植を待つ間、患者の安定を保つという重要な機能により、移植への橋渡し分野は予測期間中に最も高いCAGRが見込まれます。補助人工心臓は、2～6ヵ月間必要な機械的サポートを提供することで、患者の予後を改善します。BTT療法の有効性に対する理解が深まるにつれて、心不全治療への幅広い利用が促進されます。

最大のシェアを占める地域

北米における心不全率の増加と医療機器の技術開拓が相まって、目的地や移植への橋渡し療法としての補助弁装置（VAD）の需要が高まっているためです。さらに、補助人工心臓は、移植に利用できるドナーの心臓が不十分な場合に重要な代用品となり、患者の永続的な生存や移植を待つ間の生存を支援します。

CAGRが最も高い地域：

アジア太平洋地域は、中国、インド、日本、韓国による最新の医療技術やヘルスケア・インフラへの投資の増加により、予測期間中に最も高い成長率を示すと予測されています。洗練された心不全管理ソリューションへのニーズは、意識の高まりと診断能力の強化によって高まっています。アジア太平洋の補助人工心臓（VAD）市場は、小型でより効果的な、問題の少ないデバイスの開発を含む技術開発の結果として拡大しています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品発売
事業拡大
その他の主要戦略

第12章企業プロファイリング

Abiomed Inc.
BiVACOR Inc.
Abbott Laboratories
Berlin Heart GmbH
Calon Cardio
Medtronic PLC
SynCardia Systems LLC
Terumo Corporation
Jarvik Heart Inc.
ReliantHeart, Inc.
Sun Medical Technology Research Corp

図表

List of Tables

Table 1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)

Product Code: SMRC27556

According to Stratistics MRC, the Global Ventricular Assist Devices Market is accounted for $3.6 billion in 2024 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 19.6% during the forecast period. Mechanical pumps called Ventricular Assist Devices (VADs) help the ventricles pump blood to the body, hence supporting heart function. Patients who are not candidates for transplant surgery, have significant heart failure, or are awaiting a heart transplant frequently utilize them. VADs can be inserted into one or both ventricles, the most frequent being the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). They raise the standard of living for patients, increase blood flow, and lessen cardiac strain.

According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.

Market Dynamics:

Driver:

Global prevalence of heart failure

In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.

Restraint:

Risks associated with implantation

Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.

Opportunity:

Continuous innovations in VAD technology

Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.

Threat:

Inadequate reimbursement policies and insurance coverage

VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.

The biventricular assist devices segment is expected to be the largest during the forecast period

The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.

Region with largest share:

North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.

Region with highest CAGR:

Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.

Key players in the market

Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .

Key Developments:

In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.

In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.

In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.

Products Covered:

Left Ventricular Assist Device
Right Ventricular Assist Device
Biventricular Assist Device
Total Artificial Heart

Designs Covered:

Implantable Ventricular Assist Devices
Transcutaneous Ventricular Assist Devices

Type of Flows Covered:

Pulsatile Flow VAD
Continuous Flow VAD

Applications Covered:

Bridge-to-Transplant
Destination Therapy
Bridge-to-Recovery
Bridge-to-Candidacy

End Users Covered:

Hospitals
Cardiac Surgery Centers
Home Care Agencies
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Ventricular Assist Devices Market, By Product

5.1 Introduction
5.2 Left Ventricular Assist Device
5.3 Right Ventricular Assist Device
5.4 Biventricular Assist Device
5.5 Total Artificial Heart

6 Global Ventricular Assist Devices Market, By Design

6.1 Introduction
6.2 Implantable Ventricular Assist Devices
6.3 Transcutaneous Ventricular Assist Devices

7 Global Ventricular Assist Devices Market, By Type of Flow

7.1 Introduction
7.2 Pulsatile Flow VAD
7.3 Continuous Flow VAD

8 Global Ventricular Assist Devices Market, By Application

8.1 Introduction
8.2 Bridge-to-Transplant
8.3 Destination Therapy
8.4 Bridge-to-Recovery
8.5 Bridge-to-Candidacy

9 Global Ventricular Assist Devices Market, By End User

9.1 Introduction
9.2 Hospitals
9.3 Cardiac Surgery Centers
9.4 Home Care Agencies
9.5 Other End Users

10 Global Ventricular Assist Devices Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Abiomed Inc.
12.2 BiVACOR Inc.
12.3 Abbott Laboratories
12.4 Berlin Heart GmbH
12.5 Calon Cardio
12.6 Medtronic PLC
12.7 SynCardia Systems LLC
12.8 Terumo Corporation
12.9 Jarvik Heart Inc.
12.10 ReliantHeart, Inc.
12.11 Sun Medical Technology Research Corp

補助人工心臓（VAD）市場の2030年までの予測：製品別、設計別、フロータイプ別、用途別、エンドユーザー別、地域別の世界分析

Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product, Design, Type of Flow, Application, End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の補助人工心臓（VAD）市場：製品別

第6章 世界の補助人工心臓（VAD）市場：設計別

第7章 世界の補助人工心臓（VAD）市場：フロータイプ別

第8章 世界の補助人工心臓（VAD）市場：用途別

第9章 世界の補助人工心臓（VAD）市場：エンドユーザー別

第10章 世界の補助人工心臓（VAD）市場：地域別

第11章 主な発展

第12章 企業プロファイリング